{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:45:10Z","timestamp":1779342310688,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005339","name":"American Academy of Neurology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005339","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Epidemiology and Biostatistics of Aging Training Grant","award":["T32 AG000247"],"award-info":[{"award-number":["T32 AG000247"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.vaccine.2011.09.123","type":"journal-article","created":{"date-parts":[[2011,10,16]],"date-time":"2011-10-16T20:14:27Z","timestamp":1318796067000},"page":"9697-9701","source":"Crossref","is-referenced-by-count":31,"title":["Guillain\u2013Barr\u00e9 Syndrome in India: Population-based validation of the Brighton criteria"],"prefix":"10.1016","volume":"29","author":[{"given":"Farrah J.","family":"Mateen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Cornblath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell T.","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devendra","family":"Khandit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bina","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2011.09.123_bib0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain\u2013Barr\u00e9 syndrome worldwide","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"issue":"11","key":"10.1016\/j.vaccine.2011.09.123_bib0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States 1976\u20137","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.09.123_bib0015","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1212\/WNL.30.9.929","article-title":"Fatal Guillain\u2013Barr\u00e9 syndrome after the national immunization program","volume":"30","author":"Keenlyside","year":"1980","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.vaccine.2011.09.123_bib0020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa1008553","article-title":"Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China","volume":"364","author":"Liang","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.09.123_bib0025","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"issue":"4997","key":"10.1016\/j.vaccine.2011.09.123_bib0030","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.123_bib0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.123_bib0040","series-title":"Acute onset flaccid paralysis","year":"1993"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.123_bib0045","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s12098-009-0125-y","article-title":"Outcome in childhood Guillain\u2013Barr\u00e9 Syndrome","volume":"76","author":"Kalra","year":"2009","journal-title":"Ind J Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.123_bib0050","first-page":"172","article-title":"Outcomes in the Guillain\u2013Barr\u00e9 syndrome: the role of steroids","volume":"44","author":"Peter","year":"1996","journal-title":"J Assoc Physicians India"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2011.09.123_bib0055","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain\u2013Barr\u00e9 syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"issue":"15","key":"10.1016\/j.vaccine.2011.09.123_bib0060","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1212\/01.wnl.0000265396.87983.bd","article-title":"Patterns of Guillain\u2013Barr\u00e9 syndrome in children results from a Mexican population","volume":"69","author":"Nachamkin","year":"2007","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.vaccine.2011.09.123_bib0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","article-title":"Axonal variant of Guillain\u2013Barr\u00e9 syndrome associated with Campylobacter infection in Bangladesh","volume":"74","author":"Islam","year":"2010","journal-title":"Neurology"},{"issue":"9582","key":"10.1016\/j.vaccine.2011.09.123_bib0070","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0140-6736(07)60610-2","article-title":"Surveillance of acute flaccid paralysis in India","volume":"369","author":"Francis","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.09.123_bib0075","unstructured":"National Polio Surveillance Project. National Expert Review Committee (ERC). http:\/\/www.npspindia.org\/Expert.asp [last accessed 20.05.11]."},{"issue":"pt 9","key":"10.1016\/j.vaccine.2011.09.123_bib0080","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain\u2013Barr\u00e9 syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.vaccine.2011.09.123_bib0085","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain\u2013Barr\u00e9 syndrome: clinical associations and outcome","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.123_bib0090","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0022-510X(68)90063-4","article-title":"Landry\u2013Guillain\u2013Barr\u00e9\u2013Strohl syndrome in India","volume":"7","author":"Chhuttani","year":"1968","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.123_bib0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/02724936.1994.11747730","article-title":"Guillain\u2013Barr\u00e9 syndrome. A prospective clinical study in 25 children and comparison with adults","volume":"14","author":"Sarada","year":"1994","journal-title":"Ann Trop Paediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.123_bib0100","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp.2010.226639","article-title":"Guillain\u2013Barr\u00e9 syndrome subtypes related to Campylobacter infection","volume":"82","author":"Drenthen","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.vaccine.2011.09.123_bib0105","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.vaccine.2011.01.007","article-title":"Guillain\u2013Barr\u00e9 syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition","volume":"29","author":"Choe","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11015787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11015787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T07:53:21Z","timestamp":1543478001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11015787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":21,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0264410X11015787"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.123","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}